Rapid Micro Biosystems (RPID) Other Non Operating Income (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Other Non Operating Income of -$32000.0 for Q1 2026, up 34.69% on a YoY basis from -$23757.6 in Q1 2025, and down 140.0% sequentially from $80000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Other Non Operating Income (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Other Non Operating Income data on file, last reported at -$32000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 34.69% year-over-year to -$32000.0; the trailing twelve-month figure through Mar 2026 stood at -$81000.0 (up 38.64% YoY), and the FY2025 full-year result was -$110000.0, up 1.79% from the prior year.
- Other Non Operating Income retreated to -$32000.0 in Q1 2026, from $80000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $107000.0 in Q2 2022 to a low of -$79000.0 in Q3 2025.
- A 5-year average of -$15647.1 and a median of -$23000.0 in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income jumped 1237.5% in 2022 and tumbled 163.64% in 2024, its largest moves.
- Tracing RPID's Other Non Operating Income over 5 years: stood at -$11000.0 in 2022, then tumbled by 54.55% to -$17000.0 in 2023, then declined by 23.53% to -$21000.0 in 2024, then soared by 480.95% to $80000.0 in 2025, then slumped by 140.0% to -$32000.0 in 2026.
- Business Quant data shows RPID's Other Non Operating Income at -$32000.0 in Q1 2026, $80000.0 in Q4 2025, and -$79000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | -79,000.00 |
| Jun 30, 2025 | -50,000.00 |
| Mar 31, 2025 | -49,000.00 |
| Dec 31, 2024 | -21,000.00 |
| Sep 30, 2024 | -39,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | -17,000.00 |
| Sep 30, 2023 | -26,000.00 |
| Jun 30, 2023 | -29,000.00 |
| Mar 31, 2023 | -11,000.00 |
| Dec 31, 2022 | -11,000.00 |
| Sep 30, 2022 | -21,000.00 |
| Jun 30, 2022 | 107,000.00 |
| Mar 31, 2022 | -16,000.00 |
| Dec 31, 2021 | 2.25 Mn |
| Sep 30, 2021 | -3.10 Mn |
| Jun 30, 2021 | 8,000.00 |